An observational study in Liver Cirrhosis, sponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran. Status unknown at 1 site in Mexico. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-03-02.
Sponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Observational
Liver transplant is the goal treatment for every patient with end-stage chronic liver disease.
Quality of life improves after transplant because the main complications of end-stage liver disease disappear, but due to immunosuppression other alterations appear such as metabolic alterations, weight gain, among others.
Body composition and nutritional status can be affected do to post-transplant pharmacologic therapy.
Body composition and nutritional status can be affected due to post-transplant pharmacologic therapy.
This is a prospective cohort study, patients from liver transplant waiting list will be assessed, pre and post-transplant measures of body composition and nutritional status will be obtained.
1,668 studies on the registry are indexed under Liver Cirrhosis; 360 are open to participants now.
This study's planned enrollment of 60 is below the median of 152 across 605 observational studies indexed under Liver Cirrhosis.
Browse Liver Cirrhosis studies →Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran is the lead sponsor of 144 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients will be selected from the transplant enrollment list at the Department of Gastroenterology in a tertiary care center in Mexico
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Nutritional assessment will be performed by bioelectrical impedance vector analysis
Body composition
Body composition will be assessed through bioelectrical impedance vector analysis graph.
Time frame: Baseline, 7 days, 1 month, 3 months and 6 months post-tranpslant
Liver function tests
Time frame: Baseline, 7 days, 1 month, 3 months and 6 months post-tranpslant
This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran →